Compare RCUS & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Andersons Inc is diversified company with its main focus in agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment which generates the majority of the revenue is engaged in movement of physical commodities such as; whole grains, grain products, feed ingredients and domestic fuel products among other agricultural commodities. Geographically, the company generates majority of its revenue from United States and rest from Canada, Mexico, Egypt, Switzerland and other markets.